Mark S. MD Gelder - Aug 2, 2022 Form 4 Insider Report for Onconova Therapeutics, Inc. (ONTX)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Mark Guerin, Attorney-in-Fact
Stock symbol
ONTX
Transactions as of
Aug 2, 2022
Transactions value $
-$1,498
Form type
4
Date filed
8/4/2022, 04:34 PM
Previous filing
Feb 9, 2022
Next filing
Feb 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONTX Common Stock Options Exercise +4.65K +195.3% 7.03K Aug 2, 2022 Direct F1
transaction ONTX Common Stock Tax liability -$1.5K -1.14K -16.14% $1.32 5.9K Aug 3, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Restricted Stock Units Options Exercise $0 -4.65K -33.33% $0.00 9.3K Aug 2, 2022 Common Stock 4.65K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On August 2, 2021 the reporting person was granted 13,950 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.